K. Rossbach, “Histamine 2 Receptor Agonism and Histamine 4 Receptor Antagonism Ameliorate Inflammation in a Model of Psoriasis”, Acta Derm Venereol, vol. 100, no. 19, pp. 1–8, Dec. 2020.